Marc S. Penn,Rahul Aras,Joseph Pastore,Timothy R. Miller
申请号：
US13393141
公开号：
US20120283315A1
申请日:
2010.08.30
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A method of treating a cardiomyopathy in a subject includes administering directly to or expressing locally in a weakened, ischemic, and/or peri-infarct region of myocardial tissue of the subject an amount of SDF-1 effective to cause functional improvement in at least one of the following parameters: left ventricular volume, left ventricular area, left ventricular dimension, cardiac function, 6-minute walk test, or New York Heart Association (NYHA) functional classification.
